. Author manuscript; available in PMC: 2010 Nov 15.

Published in final edited form as: Clin Cancer Res. 2009 Oct 27;15(22):6862–6870. doi: 10.1158/1078-0432.CCR-09-1315

Table 1.

Comparative efficacy of TKI in BA/F3 KIT double mutants, harboring either a KIT exon 9 or exon 11 primary mutation